Metoprolol Krka (Metoprolol Succinate)

Metoprolol Krka is a selective β1‑adrenergic blocker used in cardiovascular disease management.

• Hypertension: lowers systolic and diastolic blood pressure to reduce cardiovascular risk.
• Angina pectoris: decreases myocardial oxygen demand, relieving chest pain.
• Heart failure: improves left‑ventricular function and reduces hospitalisation.
• Post‑myocardial infarction: lowers the chance of recurrent ischemic events and improves survival.

• Metoprolol Succinate selectively antagonises β1‑adrenergic receptors in cardiac tissue, reducing cyclic AMP formation. This leads to decreased heart rate, contractility, and renin release, ultimately lowering cardiac output and peripheral vascular resistance, which helps control blood pressure and myocardial oxygen consumption.

Metoprolol Krka may cause a range of adverse reactions, from mild to serious.

Common Side Effects

• Fatigue: feeling unusually tired or weak.
• Dizziness: light‑headedness, especially when standing quickly.
• Bradycardia: slower than normal heart rate.
• Cold extremities: reduced blood flow to hands and feet.
• Gastrointestinal upset: nausea or abdominal discomfort.
• Headache: mild to moderate pain.

Serious or Rare Side Effects

• Severe bradycardia: heart rate dropping to dangerously low levels.
• Heart block: impaired electrical conduction in the heart.
• Hypotension: significant drop in blood pressure causing faintness.
• Bronchospasm: narrowing of airways, particularly in asthmatic patients.
• Allergic reactions: rash, itching, swelling, or anaphylaxis.
• Depression or mood changes: emerging or worsening depressive symptoms.

Before initiating Metoprolol Krka, clinicians should consider several safety measures.

• Monitor blood pressure: check regularly to avoid excessive hypotension.
• Assess cardiac function: evaluate heart rate and rhythm, especially in patients with conduction disorders.
• Adjust in renal/hepatic impairment: dose may need modification in reduced organ function.
• Caution in asthma/COPD: β1‑selectivity may still affect bronchial tone.
• Avoid abrupt discontinuation: taper gradually to prevent rebound tachycardia.
• Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Metoprolol Krka can interact with other medicines, altering its efficacy or safety.

Major Interactions (Avoid)

• Verapamil or diltiazem: combined effect may cause severe bradycardia or heart block.
• Clonidine withdrawal: abrupt stop of clonidine while on metoprolol can precipitate hypertension.
• Amiodarone: may increase metoprolol plasma levels, leading to excessive β‑blockade.

Moderate Interactions (Monitor Closely)

• Insulin or oral hypoglycemics: metoprolol can mask hypoglycaemia symptoms.
• NSAIDs: may reduce antihypertensive effect of metoprolol, requiring BP monitoring.